• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. CRYOPATCH SG PULMONARY HEMI-ARTERY; HEART VALVE, MORE THAN MINIMALLY MANIPULATED ALLOGRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. CRYOPATCH SG PULMONARY HEMI-ARTERY; HEART VALVE, MORE THAN MINIMALLY MANIPULATED ALLOGRAFT Back to Search Results
Model Number SGPH00
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Congenital Defect/Deformity (1782)
Event Date 06/02/2020
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Event Description
According to the initial report received on 7/31/2020, patient had hypoplastic left heart.On (b)(6) 2020 sgph00 serial number (b)(4) was implanted as part of norwood procedure.On (b)(6) 2020 patient received a heart cath stent lpa.On (b)(6) 2020 the patient underwent a heart transplant.
 
Manufacturer Narrative
The available information was reviewed.The certificate of assurance for cryopatch sg pulmonary hemi-artery 11487387 was reviewed.All attributes identified during inspection were documented appropriately on the certificate of assurance.There are no rejectable attributes.Given the limited information available we know the patient is a 4-month-old presenting with hypoplastic left heart (hypoplastic left heart syndrome, hlhs) and received the 60mm x 4.0cm cryopatch sg pulmonary hemi-artery (sid (b)(6)) on (b)(6) 2020.The implant summary card for this patch indicates the patch was used for a norwood procedure, although no operative notes are available at this time, so it is unknow as to how or where the patch was used during this surgical procedure.Approximately 6 weeks post-operative, it was reported that the patient underwent a heart catherization on (b)(6) 2020.It appears that a stent was placed into the lpa, which presumably is the left pulmonary artery.Stent placement would have been to treat a stenosis in this anatomic location and is considered standard of care.As we do not know where the patch was placed during the incident operation, it remains unclear if the stent placement involved the patch material directly or native artery or a combination of both.Seven weeks later it was reported that this patient underwent a heart transplant procedure, which is a well-established treatment option for patients with hlhs.The root cause of the reported events and the relation to the branch patch cannot be determined from the available information.Fibrosis and technical complications related to surgical technique cannot be excluded.¿graft stricture" is listed in the cryopatch sg ifu as a potential known adverse event associated with the use of patch material in cardiac reconstruction (cryopatch sg ifu).No increase in occurrence has occurred.No new risks were identified.All risks identified have been mitigated as far as possible and residual risk is acceptable.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to cryolife is accurate or has been confirmed by cryolife.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CRYOPATCH SG PULMONARY HEMI-ARTERY
Type of Device
HEART VALVE, MORE THAN MINIMALLY MANIPULATED ALLOGRAFT
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd. nw
kennesaw GA 30144
MDR Report Key10459375
MDR Text Key204538107
Report Number1063481-2020-00014
Device Sequence Number1
Product Code OHA
Combination Product (y/n)N
PMA/PMN Number
K092021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 10/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/27/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model NumberSGPH00
Was Device Available for Evaluation? No
Date Manufacturer Received07/31/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-